The adenosine A2A receptor (A2AR), dopamine D2 receptor (D2R) and metabotropic
glutamate receptor type 5 (mGluR5) form A2AR-D2R-mGluR5 heteroreceptor complexes in …

Recently evidence has been presented that adenosine A2A and dopamine D2 receptors
form functional heteromeric receptor complexes as demonstrated in human neuroblastoma …

Evidence for heteromeric receptor complexes comprising adenosine A2A and metabotropic
glutamate 5 (mGlu5) receptors in striatum has raised the possibility of synergistic …

In 6-hydroxydopamine-lesioned rats, the selective mGlu5 receptor agonist (RS)-2-Cholro-5-
Hydroxyphenylglycine (CHPG, 1-6 μg/10 μl intracerebroventricularly) significantly inhibited …

G protein‐coupled receptors are known to form homo‐and heteromers at the plasma
membrane, but the stoichiometry of these receptor oligomers are relatively unknown. Here …

The physiological meaning of the coexpression of adenosine A2A receptors and group I
metabotropic glutamate receptors in γ-aminobutyric acid (GABA) ergic striatal neurons is …

The present manuscript mainly summarizes the basic concepts and the molecular
mechanisms underlying adenosine A2A-dopamine D2 receptor–receptor interactions in the …

The adenosine homo, iso and heteroreceptor complexes in the basal ganglia play a highly
significant role in modulating the indirect and direct pathways and the striosomal projections …

The anti‐Parkinsonian effect of glutamate metabotropic group 5 (mGluR5) and adenosine
A2A receptor antagonists is believed to result from their ability to postsynaptically control the …

Heteromers of G-protein-coupled receptors (GPCRs) have emerged as potential novel
targets for drug development. Accumulating evidence indicates that GPCRs can form …